Your browser doesn't support javascript.
loading
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.
Canu, Letizia; Van Hemert, Janna A W; Kerstens, Michiel N; Hartman, Robert P; Khanna, Aakanksha; Kraljevic, Ivana; Kastelan, Darko; Badiu, Corin; Ambroziak, Urszula; Tabarin, Antoine; Haissaguerre, Magalie; Buitenwerf, Edward; Visser, Anneke; Mannelli, Massimo; Arlt, Wiebke; Chortis, Vasileios; Bourdeau, Isabelle; Gagnon, Nadia; Buchy, Marie; Borson-Chazot, Francoise; Deutschbein, Timo; Fassnacht, Martin; Hubalewska-Dydejczyk, Alicja; Motyka, Marcin; Rzepka, Ewelina; Casey, Ruth T; Challis, Benjamin G; Quinkler, Marcus; Vroonen, Laurent; Spyroglou, Ariadni; Beuschlein, Felix; Lamas, Cristina; Young, William F; Bancos, Irina; Timmers, Henri J L M.
Afiliación
  • Canu L; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Van Hemert JAW; Department of Experimental and Clinical Biomedical Sciences University of Florence, Florence, Italy.
  • Kerstens MN; Department of Internal Medicine, Division of Endocrinology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Hartman RP; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Khanna A; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
  • Kraljevic I; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
  • Kastelan D; Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Badiu C; Department of Endocrinology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Ambroziak U; National Institute of Endocrinology C. I. Parhon, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Tabarin A; Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
  • Haissaguerre M; Service d'Endocrinologie Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France.
  • Buitenwerf E; Service d'Endocrinologie Hôpital Haut-Lévêque, CHU de Bordeaux, Pessac, France.
  • Visser A; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
  • Mannelli M; Department of Applied Health Research, University of Groningen, University Medical Center Groningen, GZ Groningen, Netherlands.
  • Arlt W; Department of Experimental and Clinical Biomedical Sciences University of Florence, Florence, Italy.
  • Chortis V; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Bourdeau I; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
  • Gagnon N; Division of Endocrinology, Center Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Buchy M; Division of Endocrinology, Center Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Borson-Chazot F; Fédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Deutschbein T; Fédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France.
  • Fassnacht M; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Wuerzburg, Germany.
  • Hubalewska-Dydejczyk A; Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Wuerzburg, Wuerzburg, Germany.
  • Motyka M; Comprehensive Cancer Center Mainfranken, University of Wuerzburg, Wuerzburg, Germany.
  • Rzepka E; Department of Endocrinology, Jagiellonian University, Collegium Medicum, Krakow, Poland.
  • Casey RT; Department of Endocrinology, Jagiellonian University, Collegium Medicum, Krakow, Poland.
  • Challis BG; Department of Endocrinology, Jagiellonian University, Collegium Medicum, Krakow, Poland.
  • Quinkler M; Addenbrooke's Hospital, Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and NIHR Biomedical Research Center, Cambridge, United Kingdom.
  • Vroonen L; Addenbrooke's Hospital, Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge and NIHR Biomedical Research Center, Cambridge, United Kingdom.
  • Spyroglou A; Endocrinology in Charlottenburg, Berlin, Germany.
  • Beuschlein F; Department of Endocrinology, Center Hospitalier Universitaire de Liège, Liège, Belgium.
  • Lamas C; Medizinische Klinik und Poliklinik IV Ludwig-Maximilians-Universität München, Munich, Germany.
  • Young WF; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zurich, Switzerland.
  • Bancos I; Medizinische Klinik und Poliklinik IV Ludwig-Maximilians-Universität München, Munich, Germany.
  • Timmers HJLM; Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zurich, Switzerland.
J Clin Endocrinol Metab ; 104(2): 312-318, 2019 02 01.
Article en En | MEDLINE | ID: mdl-30383267
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Feocromocitoma / Neoplasias de las Glándulas Suprarrenales Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article